Cannabis, Cannabinoids, and Stroke: Increased Risk or Potential for Protection—A Narrative Review
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Worldwide, approximately 15 million people per year suffer from stroke. With about 5 million deaths, stroke is the second most common cause of death and a major cause of long-term disability. It is estimated that about 25% of people older than 85 years will develop stroke. Cannabis sativa and derived cannabinoids have been used for recreational and medical purposes for many centuries. However, due to the legal status in the past, research faced restrictions, and cannabis use was stigmatized for potential negative impacts on health. With the changes in legal status in many countries of the world, cannabis and cannabis-derived substances such as cannabinoids and terpenes have gained more interest in medical research. Several medical effects of cannabis have been scientifically proven, and potential risks identified. In the context of stroke, the role of cannabis is controversial. The negative impact of cannabis use on stroke has been reported through case reports and population-based studies. However, potential beneficial effects of specific cannabinoids are described in animal studies under certain conditions. In this narrative review, the existing body of evidence regarding the negative and positive impacts of cannabis use prior to stroke will be critically appraised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rigorous studies supporting these positive effects are missing [72].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is a strong temporal link between cannabis exposure and the occurrence of stroke (i.e., ischemic), including chronic use and acute intoxication with onset ranging from “24 h” to “days before preceding the events” [72].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapter 12: What does the Anthropocene hold for citizenship?
(2019) · edoc (University of Basel) · doi:10.1007/978-3 · Cited by 11,533
Easton, J. D., Saver, J. L., Albers, G. W., Alberts, M. J., Chaturvedi, S., Feldmann, E., Hatsukami, T. S., Higashida, R. T., Johnston, S. C., Kidwell, C. S., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.192218 · Cited by 1,845
Johnston, L., Miech, R., & O'Malley, P. (2020) · doi:10.3998/2027.42/162579 · Cited by 1,611 · cited 2×
“In addition, the severity of stroke was pronounced in cannabis users, evidenced by significantly more hospitalizations in the cannabis users compared to nonusers [28,29].”
BackgroundZou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,343 · cited 6×
“AEA is produced in response to certain stimuli from glycerophospholipids by N-acyltransferase or N-acyl-phosphatidylethannolamine-specific phospholipase D (NAPE-PLD) [11].”
BackgroundInfluentialCannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970 · cited 3×
“Both CB1 and CB2 receptor activation causes inhibition of adenylate cyclase activation by Gi or Go signaling processes, which results in an overall reduction in cyclic adenosine monophosphate (cAMP) production [6].”
BackgroundTriggering Myocardial Infarction by Marijuana
Mittleman, M. A., Lewis, R. A., Maclure, M., Sherwood, J. B., & Muller, J. E. (2001) · Circulation · doi:10.1161/01.cir.103.23.2805 · Cited by 767 · cited 2×
“Studies report that the hour immediately after smoking is a critical time point [36]; the risk of stroke increases significantly by about 4.8-fold [26].”
BackgroundResultInfluentialShen, M., Piser, T. M., Seybold, V. S., & Thayer, S. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04322.1996 · Cited by 604 · cited 1×
“FOR PEER REVIEW Research involving rat hippocampal cultures has demonstrated that activating CB1 can inhibit the release of glutamate presynaptically, thus protecting against glutamate-induced excitotoxicity [66].”
BackgroundCannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures
Nagayama, T., Sinor, A. D., Simon, R. P., Chen, J., Graham, S. H., Jin, K., & Greenberg, D. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-02987.1999 · Cited by 468 · cited 3×
“These channels are involved in the release of the neurotransmitter, glutamate, which has been shown to be related to neuronal death in several hypoxic and ischemic models [63].”
BackgroundMethodInfluentialCardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 439 · cited 2×
“…potential sources for clot-for-mation-inducing ischemic Studies have found that the CB1 receptor activation may contribute to plaque development in blood vessels, while the CB2 receptor contributes to reduced plaque development, providing a protective effect [59]. stroke related to cannabis use.”
BackgroundThe Endocannabinoid System and its Modulation by Phytocannabinoids
Di Marzo, V., & Piscitelli, F. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0374-6 · Cited by 432
Westover, A. N., McBride, S., & Haley, R. W. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.495 · Cited by 324 · cited 1×
“The increase in cannabis users was reported as 1.8 [26], 2.3 [23], and most commonly 4.5 to 5-fold [10,27] in comparison to nonusers [7,24–26] throughout different studies [7,26].”
BackgroundInfluentialThomas, G., Kloner, R. A., & Rezkalla, S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.042 · Cited by 302 · cited 1×
“It has been found that reversible cerebral vasoconstriction syndrome was reversed when cannabis use was ceased [52].”
BackgroundPharmacology of Medical Cannabis
Amin, M. R., & Ali, D. W. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-21737-2_8 · Cited by 278 · cited 1×
“Therapeutic actions of THC and CBD include the ability to act as anti-inflammatory agents, and neuroprotection [8].”
BackgroundPage, R. L., Allen, L. A., Kloner, R. A., Carriker, C. R., Martel, C., Morris, A. A., Piano, M. R., Rana, J. S., Saucedo, J. F., & On behalf of the American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; and Council on Quality of Care and Outcomes Research (2020) · Circulation · doi:10.1161/cir.0000000000000883 · Cited by 260
Turcotte, C., Chouinard, F., Lefebvre, J. S., & Flamand, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-021r · Cited by 243 · cited 2×
“…consumption showed increased platelet aggregation, and platelets were found to be positive for both the CB1 and CB2 receptor, indicating that platelets may represent a way that cannabis is inducing stroke [58]. aggregation, which may contribute to the formation of a cerebral blood clot [57].”
BackgroundIncreased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice
Parmentier-Batteur, S., Jin, K., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09771.2002 · Cited by 225
Role of cannabis in cardiovascular disorders
Goyal, H., Awad, H. H., & Ghali, J. K. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.06.104 · Cited by 224
Endocannabinoid system in neurodegenerative disorders
Basavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14098 · Cited by 212 · cited 1×
“Phytocannabinoids, including THC and CBD, also elicit their effects by binding to the cell membrane receptors of CB1 or CB2 [12].”
BackgroundWolff, V., Lauer, V., Rouyer, O., Sellal, F., Meyer, N., Raul, J. S., Sabourdy, C., Boujan, F., Jahn, C., Beaujeux, R., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.610915 · Cited by 197 · cited 5×
“In a prospective study of 48 young patients who had a stroke, reversible cerebral vasoconstriction was found to be a mechanism, and in follow-up, this effect of vasoconstriction was reversed in those who had stopped their cannabis use [27].”
BackgroundInfluentialCardiovascular Complications of Marijuana and Related Substances: A Review
Singh, A., Saluja, S., Kumar, A., Agrawal, S., Thind, M., Nanda, S., & Shirani, J. (2018) · Cardiology and Therapy · doi:10.1007/s40119-017-0102-x · Cited by 169
Wolff, V., Schlagowski, A.-I., Rouyer, O., Charles, A., Singh, F., Auger, C., Schini‐Kerth, V. B., Marescaux, C., Raul, J., Zoll, J., et al. (2015) · BioMed Research International · doi:10.1155/2015/323706 · Cited by 166 · cited 2×
“The most evidence for potential mechanisms of cannabis-induced stroke exists for the reversible cerebral vasoconstriction syndrome [1,2,5,7,11,13,16,21,27,49,50].”
BackgroundZhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Jallo, J. I., & Tuma, R. F. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600447 · Cited by 164
Rumalla, K., Reddy, A. Y., & Mittal, M. K. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.066 · Cited by 159 · cited 1×
“One report describes a 4.7-fold increased risk of stroke in patients who use cannabis weekly or more then weekly [42].”
BackgroundInfluential(2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64034-5.00019-5 · Cited by 158
Jouanjus, É., Raymond, V., Lapeyre‐Mestre, M., & Wolff, V. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0663-0 · Cited by 146 · cited 3×
“The incidence of cannabis-related strokes has been increasing in recent years, which coincides with cannabis being more readily accessible and widely used [22,23].”
BackgroundInfluentialCannabis-related Stroke: Myth or Reality?
Wolff, V., Armspach, J., Lauer, V., Rouyer, O., Bataillard, M., Marescaux, C., & Gény, B. (2012) · Stroke · doi:10.1161/strokeaha.112.671347 · Cited by 143 · cited 1×
“In a study looking at case reports of young people (mean age: 32 years) who had a stroke, 81% reported cannabis use [25,31].”
BackgroundA Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse
Tsatsakis, A., Docea, A. O., Calina, D., Tsarouhas, K., Zamfira, L.-M., Mitrut, R., Sharifi-Rad, J., Kovatsi, L., Siokas, V., Dardiotis, E., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091295 · Cited by 142 · cited 8×
“THC has a lack of specificity for the CB1/CB2 receptor [13] and activates both receptors.”
BackgroundMethodInfluentialFonseca, A. C., & Ferro, J. M. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0325-0 · Cited by 133 · cited 2×
“There are many different factors that can lead or contribute to the onset of a stroke, including drugs of abuse [17].”
BackgroundEcheverria-Villalobos, M., Todeschini, A. B., Stoicea, N., Fiorda‐Diaz, J., Weaver, T. E., & Bergese, S. D. (2019) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2019.03.011 · Cited by 121
Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Hillard, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740054 · Cited by 120 · cited 1×
“…looking at the effects of WIN55,212-2 in hypoxia ischemia of rats, it was found that WIN55,212-2 had a protective role, and administration of the CB2 antagonist SR144528 reversed the neuroprotective effects provided by WIN55,212-2 indicating that CB2 was necessary for this provided protection [78].”
BackgroundHeavy cannabis users at elevated risk of stroke: evidence from a general population survey
Hemachandra, D., McKetin, R., Cherbuin, N., & Anstey, K. J. (2015) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12477 · Cited by 109 · cited 1×
“Infrequent use of cannabis also does not appear to influence the stroke risk, compared to nonusers and heavy users [41].”
BackgroundCannabis and Stroke: Systematic Appraisal of Case Reports
Hackam, D. G. (2015) · Stroke · doi:10.1161/strokeaha.115.008680 · Cited by 100 · cited 4×
“The incidence of cannabis-related strokes has been increasing in recent years, which coincides with cannabis being more readily accessible and widely used [22,23].”
BackgroundInfluentialStrokes are possible complications of cannabinoids use
Wolff, V., & Jouanjus, É. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.01.031 · Cited by 98 · cited 1×
“In a study looking at case reports of young people (mean age: 32 years) who had a stroke, 81% reported cannabis use [25,31].”
BackgroundStroke after heavy marijuana smoking.
Zachariah, S. B. (1991) · Stroke · doi:10.1161/01.str.22.3.406 · Cited by 97 · cited 2×
“THC has been found to cause hypotension as well as vasospasm and cerebral infarction [55]. blood fl ow was reduced after administration of THC, though this study did not Some studies looking at THC causing hypotension found that it can lead to compensatory vasoconstriction and reversible cerebral…”
BackgroundCannabis, Ischemic Stroke, and Transient Ischemic Attack: A Case-Control Study
Barber, P. A., Pridmore, H. M., Krishnamurthy, V., Roberts, S., Spriggs, D. A., Carter, K. N., & Anderson, N. E. (2013) · Stroke · doi:10.1161/strokeaha.113.001562 · Cited by 96 · cited 1×
“When alcohol and tobacco covariates were adjusted for, the association between cannabis use and stroke was no longer present [1,47].”
BackgroundKalla, A., Krishnamoorthy, P. M., Gopalakrishnan, A., & Figueredo, V. M. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000681 · Cited by 92 · cited 2×
“In addition, cannabis users more likely had underlining health conditions or had increased risk factors including hypertension, obesity, coronary artery disease, and heart failure [33].”
BackgroundHansen, H. H., Azcoitia, Í., Pons, S., Romero, J., García‐Segura, L. M., Ramos, J. A., Hansen, H. S., & Fernández‐Ruíz, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00961.x · Cited by 87
Cerebellar Infarction in Adolescent Males Associated With Acute Marijuana Use
Geller, T. J., Loftis, L. L., & Brink, D. S. (2004) · PEDIATRICS · doi:10.1542/peds.113.4.e365 · Cited by 87 · cited 1×
“Stroke tends to occur most often in frequent and heavy users [44,45], and there is lots of evidence to suggest a dose-dependent or temporal relationship in stroke.”
BackgroundMarijuana Use Among Young Adults (18–44 Years of Age) and Risk of Stroke
Parekh, T., Pemmasani, S., & Desai, R. (2019) · Stroke · doi:10.1161/strokeaha.119.027828 · Cited by 84 · cited 1×
“Evidence also suggests that the incidence of stroke is related to the amount of cannabis used, with heavy use having the most frequency of stroke [37].”
BackgroundTherapeutic applications of cannabinoids
Maurya, N., & Velmurugan, B. K. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.018 · Cited by 83 · cited 1×
“There is a large public interest in potential therapeutic effects of cannabinoids [3].”
BackgroundFalkstedt, D., Wolff, V., Allebeck, P., Hemmingsson, T., & Danielsson, A.-K. (2017) · Stroke · doi:10.1161/strokeaha.116.015565 · Cited by 81 · cited 6×
“Cannabinoids from Cannabis sativa (i.e., phytocannabinoids) are the most widely used psychoactive drugs today [1].”
BackgroundInfluentialXu, J., Li, C. V., Yin, X., & Zhang, G. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.01.014 · Cited by 78 · cited 1×
“It has been found that upregulating GABA signaling aids in reducing injury in ischemic rat models; thus, blocking CB1 receptors should aid in producing this effect [72].”
BackgroundTime-Dependent Protection of CB2 Receptor Agonist in Stroke
Yu, S., Reiner, D. J., Shen, H., Wu, K., Liu, Q., & Wang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132487 · Cited by 76 · cited 2×
“…was 1.2%, and hemorrhagic stroke was 0.3%, which is higher than the rates observed in people who do not use cannabis (where the prevalence was 0.8% for ischemic stroke and 0.2% for hemorrhagic stroke) and stated that there is insufficient information regarding a dose responsive relationship [35].”
BackgroundInfluentialHarmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective
Archie, S. R., & Cucullo, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01481 · Cited by 74 · cited 3×
“Looking at young people who had had a stroke, 84% of the cases showed a link between cannabis use and stroke, without accounting for other substances [20], making it unknown whether cannabis use and stroke exhibits this strong association, or if it is better accounted for with other substances.”
BackgroundInfluentialUse of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association
Testai, F. D., Gorelick, P. B., Aparicio, H. J., Filbey, F. M., Gonzalez, R., Gottesman, R. F., Melis, M., Piano, M. R., Rubino, T., & Song, S. Y. (2022) · Stroke · doi:10.1161/str.0000000000000396 · Cited by 74 · cited 1×
“…blood fl ow was reduced after administration of THC, though this study did not Some studies looking at THC causing hypotension found that it can lead to compensatory vasoconstriction and reversible cerebral vasoconstriction syndrome [13,56]. assess if this later caused strokes in the animals [54].”
MethodCannabis and stroke: is there a link?
Thanvi, B., & Treadwell, S. D. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.070425 · Cited by 70
Richter, J. S., Quenardelle, V., Rouyer, O., Raul, J., Beaujeux, R., Gény, B., & Wolff, V. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00622 · Cited by 64 · cited 2×
“…blood fl ow was reduced after administration of THC, though this study did not Some studies looking at THC causing hypotension found that it can lead to compensatory vasoconstriction and reversible cerebral vasoconstriction syndrome [13,56]. assess if this later caused strokes in the animals [54].”
BackgroundMethodAmantea, D., Spagnuolo, P., Bari, M., Fezza, F., Mazzei, C., Tassorelli, C., Morrone, L. A., Corasaniti, M. T., Maccarrone, M., & Bagetta, G. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05975.x · Cited by 60
Jones, É., & Vlachou, S. (2020) · Molecules · doi:10.3390/molecules25214930 · Cited by 60
Transient Ischemic Attack in Heavy Cannabis Smokers – How ‘Safe’ Is It?
Mouzak, A., Agathos, P., Kerezoudi, E., Mantas, A., & Vourdeli-Giannakoura, E. (2000) · European Neurology · doi:10.1159/000008191 · Cited by 60
Middle cerebral artery velocity during upright posture after marijuana smoking
Mathew, R. J., Wilson, W. H., Humphreys, D. F., Lowe, J. V., & Wiethe, K. E. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03247.x · Cited by 56 · cited 1×
“Most of the mechanisms assume that cannabinoids are altering cerebral perfusion through impact on blood pressure or clot formation [48].”
BackgroundCannabis and coronary thrombosis: What is the role of platelets?
Dahdouh, Z., Roule, V., Lognoné, T., Sabatier, R., & Grollier, G. (2011) · Platelets · doi:10.3109/09537104.2011.601824 · Cited by 54 · cited 2×
“…consumption showed increased platelet aggregation, and platelets were found to be positive for both the CB1 and CB2 receptor, indicating that platelets may represent a way that cannabis is inducing stroke [58]. aggregation, which may contribute to the formation of a cerebral blood clot [57].”
BackgroundFernández-López, D., Faustino, J., Derugin, N., Wendland, M., Lizasoain, I., Moro, M. A., & Vexler, Z. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.008 · Cited by 50
High Frequency of Intracranial Arterial Stenosis and Cannabis Use in Ischaemic Stroke in the Young
Wolff, V., Armspach, J., Beaujeux, R., Manisor, M., Rouyer, O., Lauer, V., Meyer, N., Marescaux, C., & Gény, B. (2014) · Cerebrovascular Diseases · doi:10.1159/000363618 · Cited by 50 · cited 2×
“This mechanism works on the premise that THC is causing Interestingly, some studies have found a link between arterial stenosis and young cannabis users who have had a stroke [61].”
BackgroundStroke after heavy cannabis smoking.
Cooles, P., & Michaud, R. (1987) · Postgraduate medical journal · doi:10.1136/pgmj.63.740.511 · Cited by 44 · cited 1×
“Cannabis use in stroke has been found to be much more prevalent in the younger population [1], and cannabis use can be considered as an independent risk factor in stroke for ages 18–55 [33,34].”
BackgroundDrugs of Misuse: Focus on Vascular Dysfunction
Middlekauff, H. R., Cooper, Z. D., & Strauss, S. B. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.04.011 · Cited by 44 · cited 2×
“Studies report that the hour immediately after smoking is a critical time point [36]; the risk of stroke increases significantly by about 4.8-fold [26].”
BackgroundInfluentialEarly-Onset Cardiovascular Disease From Cocaine, Amphetamines, Alcohol, and Marijuana
O’Keefe, E. L., Dhore-Patil, A., & Lavie, C. J. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.06.027 · Cited by 41
Russmann, S., Winkler, A., Lövblad, K., Stanga, Z. G., & Bassetti, C. L. (2002) · European Neurology · doi:10.1159/000065511 · Cited by 40 · cited 1×
“Stroke tends to occur most often in frequent and heavy users [44,45], and there is lots of evidence to suggest a dose-dependent or temporal relationship in stroke.”
BackgroundAuger, N., Paradis, G., Low, N. C. P., Ayoub, A., He, S., & Potter, B. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01804-6 · Cited by 37 · cited 1×
“In a study of cannabis use in pregnant women, cannabis use during pregnancy was associated with a greater risk of ischemic stroke, whereas cannabis use before pregnancy was associated with hemorrhagic stroke, compared with women not using cannabis [46].”
BackgroundBraida, D., Pozzi, M., & Sala, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01634-7 · Cited by 36
Dunbar, M., de la Tremblaye, P. B., Azogu, I., & Plamondon, H. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.10.010 · Cited by 35 · cited 1×
“They found that pretreatment with AM251 lessened CA1 injury and behavioural changes, as well as reduced ischemic impacts on dopamine receptor expression and corticotropin-releasing hormone [70].”
BackgroundStroke in young cannabis users (18–49 years): National trends in hospitalizations and outcomes
Desai, R., Singh, S., Patel, K., Goyal, H., Shah, M. B., Mansuri, Z. H., Patel, S. D., Mahuwala, Z. K., Goldstein, L. B., & Qureshi, A. I. (2019) · International Journal of Stroke · doi:10.1177/1747493019895651 · Cited by 35 · cited 2×
“In addition, the severity of stroke was pronounced in cannabis users, evidenced by significantly more hospitalizations in the cannabis users compared to nonusers [28,29].”
BackgroundCerebrovascular Disease Associated with Marijuana Abuse: A Case Report
Mesec, A., Rot, U., & Grad, A. (2001) · Cerebrovascular Diseases · doi:10.1159/000047653 · Cited by 35
Ronca, R., Myers, A. M., Ganea, D., Tuma, R. F., Walker, E. A., & Ward, S. J. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.005 · Cited by 33 · cited 1×
“In all groups, they found a smaller infarct volume and protection against cognitive deficits [75].”
BackgroundCannabis and Cannabinoid Biology in Stroke
Choi, S., Mou, Y., & Silva, A. C. (2019) · Stroke · doi:10.1161/strokeaha.118.023587 · Cited by 33 · cited 1×
“THC, in particular, has been implicated in causing much of brain mitochondrial respiratory chain dysfunction and increases in oxidative stress [7,50,53].”
BackgroundCannabis Use and Stroke: Does a Risk Exist?
Swetlik, C., Migdady, I., Hasan, L. Z., Buletko, A. B., Price, C. L., & Cho, S. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000870 · Cited by 27 · cited 2×
“The most evidence for potential mechanisms of cannabis-induced stroke exists for the reversible cerebral vasoconstriction syndrome [1,2,5,7,11,13,16,21,27,49,50].”
BackgroundCannabis Smoking and Cardiovascular Health: It's Complicated
Piano, M. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.721 · Cited by 24 · cited 1×
“Many countries permit cannabis use for both recreational and medicinal use [19].”
BackgroundWolff, V., Zinchenko, I., Quenardelle, V., Rouyer, O., & Gény, B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.867 · Cited by 21 · cited 2×
“…arterial stenosis was found to be a statistically significant risk factor for stroke; however, this link only existed among the younger population [62]. study examining cannabis users compared to nonusers, arterial stenosis was found to be a statistically signi fi cant risk factor for stroke;…”
BackgroundThe CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia
Reichenbach, Z. W., Li, H., Ward, S. J., & Tuma, R. F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.041 · Cited by 19 · cited 2×
“The data demonstrated a reduction in infarct volume as well as a decrease in neurological impairment scores when compared to controls [69].”
MethodResultLatorre, J. G., & Schmidt, E. B. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0627-3 · Cited by 18
Multiple Cerebral Infarcts in a Young Patient Associated With Marijuana Use
Volpon, L. C., Sousa, C. L. M. D. M., Moreira, S. K. K., Teixeira, S. R., & Carlotti, A. P. D. C. P. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000326 · Cited by 18
Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia
Ward, S. J., Castelli, F., Reichenbach, Z. W., & Tuma, R. F. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.12.030 · Cited by 18
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury‐Induced Immunodeficiency Syndrome
Burkovskiy, I., Zhou, J., & Lehmann, C. (2016) · Microcirculation · doi:10.1111/micc.12276 · Cited by 13 · cited 2×
“The group that had undergone HI with endotoxemia along with AM630 treatment had restored leukocyte activation, indicating that blocking of the CB2 receptor could be a potential treatment for post stroke CIDS [77].”
BackgroundMethodSelf-citationTirkey, N. K., & Gupta, S. (2016) · PubMed · Cited by 13
Chapter 41 Illicit drug use/abuse and stroke
Sloan, M. A. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)93041-4 · Cited by 13
Effect of drug use in the treatment of acute ischemic stroke: A scoping review
Dabhi, N., Mastorakos, P., Sokolowski, J. D., Kellogg, R. T., & Park, M. S. (2022) · Surgical Neurology International · doi:10.25259/sni_561_2022 · Cited by 11 · cited 1×
“In another study of 23 case reports of cannabis-induced stroke, the mean age was 28 [32].”
BackgroundCannabis, serotonergic drug use and stroke in a 50‐year‐old woman
Yau, W. Y., Chu, E. K., & Lai, N. (2015) · Internal Medicine Journal · doi:10.1111/imj.12933 · Cited by 9 · cited 1×
“In a study looking at people’s marijuana consumption after having a stroke, it was reported that in one quarter of the patients, their use had increased significantly in the days leading up to stroke [43].”
BackgroundMarijuana-related Reversible Cerebral Vasoconstriction Syndrome
Mikami, T., Obata, R., Steinberg, D. I., Skliut, M., & Boniece, I. R. (2020) · Internal Medicine · doi:10.2169/internalmedicine.5687-20 · Cited by 9 · cited 1×
“Reversible cerebral vasoconstriction syndrome is a term that encompasses many syndromes related to vasoconstriction, such as vasospasms, that can later lead to the occurrence of ischemic stroke [51].”
BackgroundBietar, B., Zhou, J., & Lehmann, C. (2021) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-219109 · Cited by 8 · cited 1×
“This well-balanced process can be dysregulated, leading to systemic suppression of the peripheral immune response and increased susceptibility to infection, known as CNS injury-induced immunodepression syndrome (CIDS) [76].”
BackgroundSelf-citationGamma-Aminobutyric Acid (GABA) and the Endocannabinoids: Understanding the Risks and Opportunities
JAMES, S. P., & Bondugji, D. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99242 · Cited by 8 · cited 1×
“CB1 receptors have high expression on GABA neurons and these receptors’ activity inhibits neurotransmitter release [71].”
BackgroundReevaluating America’s Latest Pharmaceutical Trend: The Cardiovascular Risk of Cannabis
O’Keefe, E. L., Peterson, T. M., & Lavie, C. J. (2020) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2020.07.002 · Cited by 7
Sultana, S., Burkovskiy, I., Zhou, J., Kelly, M., & Lehmann, C. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0130 · Cited by 7 · cited 4×
“This same study also tested the effects of late administration of AM630 post stroke and showed that delayed CB2 inhibition leads to improvement of post-stroke outcomes [74].”
BackgroundResultInfluentialSelf-citationCerebrovascular Complications Associated with Marijuana Use
Moustafa, B., & Testai, F. D. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01113-2 · Cited by 7 · cited 9×
“Spice and K2 are two synthetic cannabinoids with a high potential for abuse, and they exhibit high affinity for the CB1 receptor [7].”
BackgroundInfluentialCerebral Infarction in Young Marijuana Smokers – Case Reports
Šimůnek, L., Krajina, A., Herzig, R., & Vališ, M. (2018) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2018.56 · Cited by 5
Research works printed but not linked: 1
- Amin, M.R., and Ali, D.W. (2019). Recent Advances in Cannabinoid Physiology and Pathology, Springer.
Cited by
Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits
Hoch, E., Volkow, N. D., Friemel, C. M., Lorenzetti, V., Freeman, T. P., & Hall, W. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01880-2 · Cited by 139
“Rigorous studies supporting these positive effects are missing [72].”
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Hasbi, A., & George, S. R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.100498 · Cited by 6
Exploring the Frontiers of Neuroinflammation: New Horizons in Research and Treatment
Rigillo, G., & Alboni, S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46100692 · Cited by 4
“However, the same receptors are also implicated in vascular dysfunction, contributing to the risk of stroke [10].”
BackgroundStork, S. D. S., Mathias, K., Gava, F., Joaquim, L. D. S., dos Santos, D., Tiscoski, A. D. B., Bonfante, S., Strickert, Y. R., Machado, R. S., Martins, H. M., et al. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01775-1 · Cited by 3
“By mitigating increased intestinal permeability, CBD can help reduce the potential for infection, widespread inflammation, and oxidative stress (Pellati et al. 2018; Iannotti et al. 2020; Viana et al. 2022; Carter et al. 2024).”
InfluentialAssociation Between Recreational Drug Use and Cardiovascular Events Post-Hospitalization in France
Mirailles, R., Delmas, C., Toupin, S., Bouleti, C., Trimaille, A., Schurtz, G., Piliero, N., Andrieu, S., Lattuca, B., Vasram, R. R., et al. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.124.011905 · Cited by 2
Metadata
- Authors
- Carter, C., Laviolette, L., Bietar, B., Zhou, J., & Lehmann, C.
- Affiliations
- Dalhousie University (CA)
- Department of Anesthesia, Dalhousie University, Halifax, NS B3H 4R2, Canada
- Corresponding author
- Carter, Caroline
- Venue
- Current Issues in Molecular Biology
- Publisher
- MDPI AG
- Published
- 2024-04-04
- Volume
- 46
- Issue
- 4
- Pages
- 3122-3133
- ISSN
- 1467-3037 (ISSN-L)
- 1467-3045
- PMC
- PMC11048784
- OpenAlex
- W4393949197
- Cited by
- 13
- References
- 84
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 2
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Current Issues in Molecular Biology (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- cannabis, cannabinoids, stroke, Cannabis sativa, terpenes, stroke risk, neuroprotection, medical cannabis, recreational cannabis use, cannabis legalization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

![Figure 2 Mechanisms of action for neuroprotection by CB1 and/or CB2 receptor activation. Information from [49,63,67,68,69].](https://figures.cochat.ai/paper-figures/66d8379459bc403ea2e12fb92304b616/cannabis-cannabinoids-and-stroke-increased-risk-or-potential-for-protectiona-figure-2.jpg)